Last updated: 01/24/2024 07:00:36

An Exploratory Study to Measure the Effect of Two Dietary Fibers on Satiety and Glycemic Parameters

GSK study ID
W7781293
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Overview
Eligibility
Locations
Study documents
Results summary
Plain language summaries
Additional information

Trial overview

Official title: An Exploratory Study to Measure the Effect of Two Dietary Fibers on Satiety and Glycemic Parameters
Trial description: This study will examine whether dietary supplementation with a combination of two dietary fibers will produce greater changes from baseline compared to control for satiety and glycemic parameters. Two strength levels (“high” and “low”) of the combination of dietary fibers will be tested.
Primary purpose:
Not applicable
Trial design:
Parallel Assignment
Masking:
Single (Investigator)
Allocation:
Randomized
Primary outcomes:

reductions energy intake from baseline

Timeframe: Basline, Visit 2 and Visit 3 (3 weeks total)

Secondary outcomes:

Glucose and Insulin Levels

Timeframe: Baseline, Visit 2 & Visit 3

Fasting Glycemic Parameters (glucose and insulin)

Timeframe: Baseline, Visit 2 & Visit 3

Subjective Appetite Ratings (SLIM Scale)

Timeframe: Baseline, Visit 2 & Visit 3

Body Weight

Timeframe: Baseline, Visit 2 & Visit 3

Interventions:
  • Dietary: dietary fiber
  • Dietary: Placebo
  • Enrollment:
    96
    Primary completion date:
    Not applicable
    Observational study model:
    Not applicable
    Time perspective:
    Not applicable
    Clinical publications:
    Not applicable
    Medical condition
    body weight
    Product
    Oligofructose, Pectin
    Collaborators
    Not applicable
    Study date(s)
    October 2011 to December 2011
    Type
    Interventional
    Phase
    Not applicable

    Participation criteria

    Sex
    Female & Male
    Age
    18 - 60 Year
    Accepts healthy volunteers
    yes
    • Male and female subjects aged 18-60 years, in good general health with a BMI 25- <35 kg/m2 will be eligible. Subjects will also be required to meet the following criteria: non-smoker, non-dieting, and regularly consuming 3 main meals a day. Subjects must be free from significant food restrictions and willing and able to comply with the study protocol including consumption of food items provided at the clinic visits.

    Trial location(s)

    This study does not involve prospective enrollment of participants.

    Study documents

    Scientific result summary
    Available language(s): English

    If you wish to request for full study report, please contact - [email protected]

    Results overview

    Refer to study documents

    Recruitment status
    Study complete
    Actual primary completion date
    Not applicable
    Actual study completion date
    Not applicable

    Plain language summaries

    Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.

    Additional information about the trial

    Additional information
    Not applicable
    Participate in clinical trial
    Access to clinical trial data by researchers
    Visit website